Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Active not recruiting 4Unknown 2Terminated 2Recruiting 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Lung Neoplasms 3Small Cell Lung Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Vascular Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Tongue Neoplasms 1Tobacco Use Disorder 1Stomach Neoplasms 1Solid Tumor, Adult 1Prostatic Neoplasms 1Neoplasms 1Mouth Neoplasms 1MR-PET Imaging 1Hip Fractures 1Endometrial Neoplasms 1Colorectal Neoplasms 1Bone Cysts, Aneurysmal 1Bone Cysts 1

Interventions

Cyclophosphamide 76Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 46Epirubicin 46Letrozole 42pyrotinib 40Fulvestrant 36Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 31exemestane 27Anastrozole 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 19Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × X-Rays × Clear all
NCT04328194 2020-03-31

Autotaxin (ATX) as a Marker for Breast Cancer

Assiut University

Phase NA Unknown
100 enrolled
Breast

Breast Neoplasms

NCT00820690 2015-08-05

LABC

Barretos Cancer Hospital

Unknown
80 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡